This article is for general informational purposes and does not constitute medical advice. Suitability for any treatment can only be determined through an in-person consultation with a qualified practitioner.
We routinely protect our faces with sunscreen, serums, and regular skincare, yet the hands — exposed to sun, water, and friction every day — are frequently left out of that routine entirely. The result is that hands can age faster and more visibly than the face, and even after extensive facial rejuvenation, ageing hands can give away the years a person has otherwise worked hard to conceal. Understanding why this happens is the first step to treating it effectively.
Why Hands Show Signs of Ageing Earlier Than Expected
The skin and soft tissue of the hands are structurally different from facial skin, and they are subjected to a unique combination of stresses that accelerate visible ageing. A clear understanding of these mechanisms helps explain why a combined treatment approach tends to outperform any single intervention.
Volume loss and visible tendons
Beneath the skin on the back of the hand sits a thin layer of subcutaneous fat that cushions and contours the tendons, veins, and small bones underneath. With age, this fat layer gradually atrophies — a process related to the same volume loss that affects the cheeks and temples of the face. As the padding diminishes:
- Tendons become more prominent, creating a visibly “stringy” or skeletal appearance, particularly when the hand is in motion or gripping.
- Veins sit closer to the surface, becoming more visually pronounced, especially in thinner-skinned individuals.
- The dorsum (back of the hand) appears sunken rather than smoothly contoured, changing the overall silhouette of the hand.
This volume loss is a structural change, and structural changes generally require a structural solution — which is one of the reasons dermal filler, rather than topical skincare alone, plays such a central role in hand rejuvenation.
Skin thinning, wrinkles and pigmentation
In addition to volume loss, the skin of the hands undergoes its own ageing process, largely driven by two factors: a lifetime of cumulative ultraviolet (UV) exposure, and the simple fact that hand skin is thinner than facial skin to begin with. Over time, this leads to:
- Collagen and elastin depletion, producing thin, crepey, or papery-feeling skin that wrinkles more easily.
- Reduced skin elasticity, meaning skin tents or folds rather than springing back smoothly.
- Solar lentigines (age spots) — flat, brown pigmented patches caused by cumulative sun damage, often the most visually ageing feature of the hands.
- A duller, less even skin tone overall, as cell turnover slows and pigment production becomes less regulated.
Because these are changes in the quality of the skin itself, rather than the volume beneath it, they typically respond best to treatments that work at a cellular level — which is where exosome therapy becomes a valuable complement to filler.
Combining Dermal Fillers and Exosomes for Hand Rejuvenation
Because aging hands involve both a loss of structural volume and a decline in skin quality, the most effective rejuvenation strategies tend to address both problems rather than just one. This is the rationale behind combining dermal fillers, which restore volume, with exosome therapy, which supports the skin’s own regenerative processes.
How dermal fillers restore volume to ageing hands
Dermal filler treatment for the hands involves injecting a soft, spreadable filler into the subcutaneous layer of the dorsum, replenishing the volume that has been lost over time. As the filler integrates with the surrounding tissue, it:
- Camouflages prominent tendons and veins, softening the skeletal appearance that can develop with age.
- Restores a smoother, more even contour to the back of the hand, similar in principle to volume restoration in the cheeks or temples.
- Improves skin quality indirectly, by providing underlying support that reduces visible skin laxity.
Hyaluronic acid fillers are commonly used for this purpose due to their soft, integrative properties, while calcium hydroxylapatite fillers (such as Radiesse) are also widely used because they offer the additional benefit of stimulating the body’s own collagen production over time, in addition to providing immediate volume.
How exosomes support skin regeneration
Exosomes are naturally occurring extracellular vesicles that cells use to communicate with one another, carrying growth factors, proteins, and genetic signalling molecules that influence how neighbouring cells behave. When introduced into the skin of the hands — typically through mesotherapy or microneedling rather than filler injection — exosomes can:
- Stimulate fibroblast activity, encouraging the production of new collagen and elastin.
- Support skin hydration and barrier function, helping to reduce the crepey texture associated with thin, ageing skin.
- Modulate pigment-producing cells, which may contribute to a more even skin tone over a course of treatment.
- Assist tissue repair and recovery, including after other procedures such as filler injection or microneedling itself.
Because exosomes work at a cellular and biological level rather than adding physical volume, they are best understood as a complement to filler rather than a replacement for it — the two treatments address different layers of the ageing process.
Benefits of combining fillers and exosomes
Treating the hands with both modalities, typically in a staged protocol, offers several practical advantages over using either treatment alone:
- Comprehensive correction — filler addresses the structural volume loss that exosomes cannot replace, while exosomes address the skin quality changes that filler alone does not significantly improve.
- Potentially more durable results — biostimulatory effects from both filler (in the case of products like Radiesse) and exosome therapy may support longer-lasting improvement in skin and tissue quality, although individual results vary.
- A more natural-looking outcome — restoring volume without also improving skin texture can leave the skin looking smooth in shape but still aged in quality; combining the two approaches treats the hand as a whole.
- A tailored, staged approach — most practitioners will restore volume with filler first, then introduce exosome therapy several weeks later once initial swelling has resolved, allowing each treatment to be assessed on its own merits before building on it.
As with any combination protocol, the specific sequencing, products, and number of sessions should be determined by a qualified practitioner based on an individual assessment of the patient’s hands, skin quality, and aesthetic goals.
FAQ About Hand Rejuvenation Treatments
How long do hand fillers last?
Most hand fillers last 12–18 months, depending on the product, treatment volume, and individual metabolism. Biostimulatory fillers may last longer by stimulating collagen production.
Are exosomes safe for hand rejuvenation?
Exosome therapy generally has a good safety profile when performed by qualified practitioners using reputable products. Mild redness or sensitivity is common, but long-term evidence is still evolving.
How many treatment sessions are needed?
Hand fillers typically require 1–2 sessions. Exosome treatments are usually performed in a series of 3–4 sessions, followed by maintenance treatments as needed.
Can hand rejuvenation improve age spots and pigmentation?
Exosomes may help improve overall skin quality and tone, but age spots are usually treated more effectively with IPL, laser treatments, or topical therapies. A combined approach may provide the best results.
A Final Word on Treatment Planning
Because hand rejuvenation involves working close to a well-developed network of superficial veins and tendons, treatment should only be carried out by a registered, appropriately trained medical practitioner. A thorough consultation — including an honest discussion of what filler and exosome therapy can and cannot achieve for your specific hands — is the best starting point for anyone considering this treatment, and should always precede any decision about products, volumes, or number of sessions.









